[Massive therapy and transplant of autologous bone marrow in childhood lymphomas and solid tumors. State of the art and perspectives].
The role of massive therapy followed by autologous bone marrow transplantation (ABMT) in pediatric tumours is reviewed. The rationale of such an approach based on dose-response relationship in clinical oncology, the usefulness of total body irradiation (TBI) as a part of conditioning regimens, and phase I and II trials with high dose drug combinations are discussed. The results of ABMT in lymphomas, sarcomas, neuroblastomas and other tumours are critically analyzed with special emphasis on prognostic factors, differences among conditioning regimens, intensive therapy morbidity and marrow purging procedures. Finally future perspectives and questions still unsolved are briefly summarized.
de Terlizzi
M
M
Bone Marrow Transplant Unit, Centre Léon Bérard, Lyon, Francia.
Philip
T
T
Toma
M G
MG
Colella
R
R
Ceci
A
A
D000970:Antineoplastic Agents; D016026:Bone Marrow Transplantation; D002648:Child; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D014916:Whole-Body Irradiation
D000970:Antineoplastic Agents
Terapia massiva e trapianto di midollo autologo nei linfomi e tumori solidi pediatrici. Stato dell'arte e prospettive.